DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Ticlopidine Hydrochloride is a drug marketed by Actavis Elizabeth, Apotex, Chartwell Rx, Mylan, Sun Pharm Inds Inc, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in TICLOPIDINE HYDROCHLORIDE is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the ticlopidine hydrochloride profile page.
A generic version of TICLOPIDINE HYDROCHLORIDE was approved as ticlopidine hydrochloride by APOTEX on July 1st, 1999.
Recent Clinical Trials for TICLOPIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Kafrelsheikh University||Phase 2/Phase 3|
|Janssen Research & Development, LLC||Phase 1|
|Merck Sharp & Dohme Corp.||Phase 2|